Verséa Pharmaceuticals is engaged in drug discovery, research, development and licensing of traditional prescription and OTC pharmaceuticals. We seek both innovative medicines in areas of a high need and improvements to established medicines to enhance patient outcomes.

We leverage our dedicated team of scientists, clinicians, experienced commercial team and access to leading researchers and technology innovators to:

• Optimize our proprietary drug-discovery platform
• Guide the direction of our product development pipeline and portfolio
• Bring differentiated products to the global market-place

In partnership with global leaders in botanical science and research our goal is to advance the understanding of the application of bioactive botanicals to create and commercialize new prescription medicines.

The Verséa Botanical-derived Therapeutics is focused on:

• The discovery of new compounds exhibiting positive therapeutic signals in targeted disease states
• Clinical development of pipeline compounds
• Submission of NDA’s for pipeline compounds into the FDA and ex-US regulatory agencies
• Commercialization of new and innovative medical therapeutics approved by regulatory agencies

Lifelong learning is an integral part of health professionals’ maintenance of competence and especially critical in the evidence-based alternative therapies space. By understanding the needs of the markets, Verséa is actively providing accredited continuing education to practitioners and patients. We are able to identify and address the gaps in knowledge within the ever-changing pharmaceutical industry. Through medical education, we are ultimately able to drive understanding, appropriate use, adherence to labeling and guidelines with the goal of improving patient outcomes.